Published in Cancer Weekly, March 29th, 2011
Martin Verhoef, President and CEO of Mira DX, said the study presented by Dr. Andrew Berchuck "is puzzling because it makes claims based on inapposite data. This is really a classic case of comparing apples and oranges."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.